德里因标签欺诈和不当存储而从四家公司扣押了20万卢比的胰岛素,其中两家已被扣押并进行样本检测. Delhi seized ₹20 lakh in insulin from four firms over label fraud and improper storage, with two booked and samples tested.

德里药品管制部门在特别执法行动中从六家检查的批发公司中四家中扣押了价值20.06万卢比的胰岛素, 理由是违反了药品和化品法和药品规则. The Delhi Drugs Control Department seized insulin worth ₹20.06 lakh from four of six inspected wholesale firms during a special enforcement drive, citing violations of the Drugs and Cosmetics Act and Drugs Rules. 胰岛素产品,包括Tresiba、Glaritus、Humalog、Apidra和Toujeo, 被发现带有涂鸦标签,表明政府或机构供应,缺乏有效的采购记录。 Insulin products, including Tresiba, Glaritus, Humalog, Apidra, and Toujeo, were found with defaced labels suggesting government or institutional supply and lacking valid purchase records. 两家公司将胰岛素储存在室温下,违反冷链要求。 Two firms stored insulin at room temperature, breaching cold chain requirements. 共没收了2 104个单位,预订了两家公司,并将样品送去进行质量测试。 A total of 2,104 units were confiscated, two firms were booked, and samples sent for quality testing. 德里卫生部长Pankaj Kumar Singh强调要对违反救生药品条例的行为采取严厉行动,重申政府对公共卫生和毒品安全的承诺。 Delhi Health Minister Pankaj Kumar Singh emphasized strict action against violations of regulations for life-saving drugs, reaffirming the government’s commitment to public health and drug safety.